• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯环己哌啶的代谢产物。

Metabolites of phencyclidine.

作者信息

Wong L K, Biemann K

出版信息

Clin Toxicol. 1976;9(4):583-91. doi: 10.3109/15563657608988160.

DOI:10.3109/15563657608988160
PMID:975754
Abstract

The results of the animal experiment demonstrate that oxidative hydroxylation is the major mode of metabolism of phencyclidine. It is evident that this process takes place in all three rings of the molecule. Hydroxylation of the piperidyl moiety probably also accounts for the formation of the N-dealkylated metabolites. Metabolism of phencyclidine in humans appears, at least in part, to be similar to that in the rat. Hydroxylation is still the principal mode in the case of humans though of a lesser extent. Metabolites hydroxylated in the phenyl moiety as well as dihydroxy derivatives of phencyclidine have so far not been observed in humans. Furthermore, most of the monohydroxy metabolites exist as conjugates in the human urine. It should also be pointed out that no metabolites have yet been detected in human blood samples.

摘要

动物实验结果表明,氧化羟基化是苯环己哌啶的主要代谢方式。显然,该过程发生在分子的所有三个环中。哌啶基部分的羟基化可能也参与了N-脱烷基代谢物的形成。苯环己哌啶在人体内的代谢至少部分与大鼠相似。羟基化仍是人类的主要代谢方式,不过程度较低。在人体内尚未观察到苯环部分羟基化的代谢物以及苯环己哌啶的二羟基衍生物。此外,大多数单羟基代谢物在人类尿液中以缀合物形式存在。还应指出的是,在人类血液样本中尚未检测到任何代谢物。

相似文献

1
Metabolites of phencyclidine.苯环己哌啶的代谢产物。
Clin Toxicol. 1976;9(4):583-91. doi: 10.3109/15563657608988160.
2
New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.新型设计药物N-(1-苯基环己基)-2-乙氧基乙胺(PCEEA)和N-(1-苯基环己基)-2-甲氧基乙胺(PCMEA):运用气相色谱/质谱技术对其在大鼠尿液中的代谢及毒理学检测的研究
J Mass Spectrom. 2008 Mar;43(3):305-16. doi: 10.1002/jms.1312.
3
Hydroxy metabolites of phencyclidine. Identification and quantitation of two novel metabolites.苯环利定的羟基代谢物。两种新型代谢物的鉴定与定量
Drug Metab Dispos. 1988 May-Jun;16(3):386-91.
4
Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog.苯环利定单羟基代谢物在犬体内的处置动力学。
J Pharmacol Exp Ther. 1986 Sep;238(3):900-4.
5
Biotransformation of phencyclidine.苯环利定的生物转化
Drug Metab Rev. 1985;16(3):285-320. doi: 10.3109/03602538508991437.
6
Some factors affecting phencyclidine biotransformation by human liver and placenta.一些影响苯环利定在人肝脏和胎盘进行生物转化的因素。
Drug Metab Dispos. 1989 May-Jun;17(3):271-4.
7
The metabolism of phencyclidine by rabbit liver preparations.苯环利定在兔肝制剂中的代谢。
Drug Metab Dispos. 1981 May-Jun;9(3):274-8.
8
Metabolism of phencyclidine by human liver microsomes.苯环利定在人肝微粒体中的代谢。
Drug Metab Dispos. 1997 May;25(5):557-63.
9
In vitro metabolism of 1-phenyl-1-cyclohexene, a pyrolysis product of phencyclidine.1-苯基-1-环己烯(苯环利定的一种热解产物)的体外代谢
Drug Metab Dispos. 1982 Nov-Dec;10(6):685-9.
10
Simultaneous determination of phencyclidine and monohydroxylated metabolites in urine of man by gas chromatography-mass fragmentography with methane chemical ionization.采用甲烷化学电离气相色谱-质谱碎片分析法同时测定人体尿液中的苯环利定及其单羟基化代谢物。
J Chromatogr. 1981 May 8;223(2):331-9. doi: 10.1016/s0378-4347(00)80105-x.

引用本文的文献

1
The dispositional kinetics of phencyclidine and its N-ethylamine analogue in rats.苯环利定及其N-乙胺类似物在大鼠体内的处置动力学。
Eur J Drug Metab Pharmacokinet. 1983 Oct-Dec;8(4):383-8. doi: 10.1007/BF03188770.
2
Clinical pharmacokinetics of non-opiate abused drugs.非阿片类滥用药物的临床药代动力学
Clin Pharmacokinet. 1989 Jan;16(1):1-26. doi: 10.2165/00003088-198916010-00001.